On the next day (17 June 2025), the Centre held its third International Advisory Board (IAB) Meeting, during which IAB members recognized the center's achievements and gave valuable recommendations for RCMI’s future development, particularly in strengthening collaborations and partnerships.
Following the meeting was a seminar delivered by Prof. Rudolf BAUER, Professor Emeritus at the Institute of Pharmaceutical Sciences, University of Graz, Austria, who expounded on the hurdles in drug development and regulatory issues of CM-derived medicines. This also provided an engaging platform for the guests to learn about the latest developments and challenges in CM-derived medicines.
